HLN
Haleon plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.60
−2.64%Institutional positioning
13F filings over the trailing two quarters
New 175Increased 427Reduced 395Sold out 61
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DODGE & COX | Increased | 149,934,507 | Aug 13, 2026 |
| DODGE & COX | Reduced | 146,539,663 | May 14, 2026 |
| FMR LLC | Increased | 120,991,250 | Aug 13, 2026 |
| FMR LLC | Increased | 113,969,159 | May 15, 2026 |
| Clearbridge Investments, LLC | Increased | 32,342,126 | Aug 13, 2026 |
| CLEARBRIDGE INVESTMENTS, LLC | Increased | 31,718,725 | May 13, 2026 |
| MORGAN STANLEY | Increased | 19,461,762 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 19,166,253 | May 15, 2026 |
| HARRIS ASSOCIATES L P | Increased | 16,833,252 | Aug 14, 2026 |
| HARDING LOEVNER LP | Reduced | 15,712,550 | May 15, 2026 |
| HARDING LOEVNER LP | Reduced | 15,414,796 | Aug 14, 2026 |
| Nuveen, LLC | Increased | 15,332,859 | Aug 11, 2026 |
| HARRIS ASSOCIATES L P | New Position | 15,032,041 | May 15, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Increased | 14,674,518 | May 14, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Reduced | 14,181,817 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings